Should every patient with left-ventricular systolic dysfunction receive implantable cardioverter-defibrillators?
Alan Kadish
Correspondence Northwestern University, Feinberg School of Medicine, Division of Cardiology, 251 E Huron, Feinberg Pavilion, Chicago, IL 60611, USA
Email a-kadish@northwestern.edu
This article has no abstract so we have provided the first paragraph of the full text.
Despite advances in the treatment of out-of-hospital cardiac arrest, such as the development of the automatic external defibrillator, cardiac arrest survival rates remain low. Thus, a strategy for the primary prevention of sudden death using ICD therapy in high-risk patients is potentially attractive.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
